Author:
Ran Zijing,Xue Xiaomei,Han Lin,Terkeltaub Robert,Merriman Tony R.,Zhao Ting,He Yuwei,Wang Can,Li Xinde,Liu Zhen,Cui Lingling,Li Hailong,Ji Aichang,Hu Shuhui,Lu Jie,Li Changgui
Abstract
ObjectiveTo clarify the relationship between serum urate (SU) decrease and visceral fat area (VFA) reduction in patients with gout.MethodsWe retrospectively analyzed 237 male gout patients who had two sets of body composition and metabolic measurements within 6 months. Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). All patients were from the specialty gout clinic of The Affiliated Hospital of Qingdao University. The multiple linear regression model evaluated the relationship between change in SU [ΔSU, (baseline SU) – (final visit SU)] and change in VFA [ΔVFA, (baseline VFA) – (final visit VFA)].ResultsULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. By multiple regression model, ΔSU was identified to be a significant determinant variable of decrease in VFA (beta, 0.302; p = 0.001).ConclusionsThe decrease in SU level is positively associated with reduced VFA. This finding provides a rationale for clinical trials to affirm whether ULT promotes loss of visceral fat in patients with gout.
Funder
National Key Research and Development Program of China
National Institutes of Health
Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Subject
Endocrinology, Diabetes and Metabolism
Reference49 articles.
1. Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors;Dehlin;Nat Rev Rheumatol,2020
2. Health Effects of Overweight and Obesity in 195 Countries Over 25 Years;Afshin;N Engl J Med,2017
3. Fructose, Uricase, and the Back-To-Africa Hypothesis;Johnson;Evol Anthropol,2010
4. Asymptomatic Hyperuricaemia: A Silent Activator of the Innate Immune System;Joosten;Nat Rev Rheumatol,2020
5. The Evolutionary Fate of the Genes Encoding the Purine Catabolic Enzymes in Hominoids, Birds, and Reptiles;Keebaugh;Mol Biol Evol,2010
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献